Current Drug Therapy

Editor-in-Chief

Stefano Palomba
Obstetrics & Gynecology Unit
ASMN-IRCCS
Reggio Emilia
(Italy)

Back

Become EABM
Become Reviewer

Current Advances in the Development of Anticancer Drugs Targeting Tyrosine Kinases of the Src Family

Volume:3   Issue: 3
Pp: 158-176
Silvia Schenone, Samantha Zanoli, Chiara Brullo, Emmanuele Crespan and Giovanni Maga
DOI: 10.2174/157488508785747862

New Targets for Therapy in Polyglutamine (polyQ) Expansion Diseases

Volume:3   Issue: 3
Pp: 177-189
Lorena Perrone and Mariarosa A.B. Melone
DOI: 10.2174/157488508785747835

Whos Winning the War? Molecular Mechanisms of Antibiotic Resistance in Helicobacter pylori

Volume:3   Issue: 3
Pp: 190-203
Kathleen R. Jones, Jeong-Heon Cha and D. Scott Merrell
DOI: 10.2174/157488508785747899

Therapy and Further Development of Anti-Leishmanial Drugs

Volume:3   Issue: 3
Pp: 204-208
Joana A. Pinto da Costa Tavares, Ali Ouaissi and Anabela Cordeiro-da-Silva
DOI: 10.2174/157488508785747871

Nanogel Engineered Polymeric Micelles for Drug Delivery

Volume:3   Issue: 3
Pp: 209-217
Supriya Shidhaye, Vishwanath Lotlikar, Sheetal Malke and Vilasrao Kadam
DOI: 10.2174/157488508785747880

Sphingomyelinase Inhibition Suggests a Possible New Strategy for the Treatment of Inflammatory Bowel Disease

Volume:3   Issue: 3
Pp: 218-225
Shinji Soeda, Akira Sakata, Takashi Ochiai, Kazuya Yasuda, Yukako Kuramoto, Hiroshi Shimeno, Akihisa Toda, Reiko Eyanagi, Sadao Hikishima, Tsutomu Yokomastu and Shirashi Shibuya
DOI: 10.2174/157488508785747853